Genomic Studies Have Identified Multiple Mechanisms of Genetic Changes in Waldenström Macroglobulinemia
Antibody-drug Conjugates in Relapsed/Refractory Multiple Myeloma: from Bench to Bedside - Springer Healthcare IME
Sequencing multiple myeloma using blood tests - ecancer
Salomon Manier
Post-Congress webinars – International Academy for Clinical Hematology (IACH)
ASH 2022: A Dexamethasone Sparing-Regimen with Daratumumab and Lenalidomide in Frail Patients with Newly-Diagnosed Multiple Myeloma: Efficacy and Safety Analysis of the Phase 3 IFM2017-03 Trial
IgA kappa/IgA lambda heavy/light chain assessment in the management of patients with IgA myeloma - Boyle - 2014 - Cancer - Wiley Online Library
Study shows that immune system holds clues to patients with high-risk smoldering myeloma likely to benefit from treatment - Dana-Farber Cancer Institute | Boston, MA
Study Shows That Immune System Holds Clues to Patients With High-Risk Smoldering Myeloma Likely to Benefit From Treatment - BroadcastMed
Springer Healthcare IME Independent, CME Accredited Symposium – The 9th COMy World Congress
Springer Healthcare IME Independent, CME Accredited Symposium – The 9th COMy World Congress
MagnetisMM-3 Results: Elranatamab in Relapsed Myeloma | Int'l Myeloma Fn
Irene Ghobrial, MD - Home | Facebook
Global Epigenetic Regulation of MicroRNAs in Multiple Myeloma | PLOS ONE
Join us tomorrow for the #ASH22 take-home messages by The IACH, Broadcasted LIVE from New Orleans
Myeloma Crowd Radio: Irene Ghobrial, MD & Salomon Manier, MD, PhD, Dana Farber 09/27 by HealthTree Podcast for MM | Health
Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant | Nature Communications
PDF) Epidemiological landscape of young patients with multiple myeloma diagnosed before 40 years of age: the French experience
Forimtamig's Effect on T-cells in Relapsed Myeloma Patients
Narrow subset of cells is responsible for metastasis in multiple myeloma, study finds - Dana-Farber Cancer Institute | Boston, MA
Dr. Karma Salem, MD – Atlanta, GA | Radiology
Next generation sequencing identifies smoldering multiple myeloma patients with a high risk of disease progression - ecancer
Immunomodulator drug-based therapy in myeloma and the occurrence of thrombosis
Myeloma Crowd Radio: Irene Ghobrial, MD & Salomon Manier, MD, PhD, Dana Farber by Myeloma Crowd Radio | Mixcloud
Dr. Amir Yosef, MD | Mankato, MN | Oncologist | US News Doctors
Springer Healthcare IME Independent, CME Accredited Symposium – The 9th COMy World Congress
